He adds theres an increased risk of drug interactions
Safety Concerns There have been reports of: Because of these problems, the FDA is stepping in
From meta-analyses including 2,171 adults with uncontrolled T2DM from 11 randomized controlled trials, adding insulin glargine to metformin monotherapy early in treatment may provide the greatest 24-week reductions in HbA1c and less symptomatic hypoglycemia benefits over regimens including SUs [21]
Theoretically, yes, you can take a break from Wegovy, but its unlikely to be recommended by clinicians as youd need to drop back down to the lowest dose should you decide to go back on the medication
This process promotes the translocation of Nrf2 to the nucleus, triggering the activation of antioxidant response elements and increasing the expression of genes involved in antioxidant defences and anti-inflammatory responses [131]
Semaglutide and tirzepatide have the strongest evidence bases
